HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Taylor Morrisette Selected Research

Gram-Negative Bacterial Infections

8/2022Real-World, Multicenter Case Series of Patients Treated with Oral Omadacycline for Resistant Gram-Negative Pathogens.
8/2021Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant Enterobacterales and Pseudomonas aeruginosa.
1/2020Real-World Experience with Ceftolozane-Tazobactam for Multidrug-Resistant Gram-Negative Bacterial Infections.
12/2019Real-World Experience With Ceftazidime-Avibactam for Multidrug-Resistant Gram-Negative Bacterial Infections.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Taylor Morrisette Research Topics

Disease

19Infections
03/2022 - 01/2019
4Gram-Negative Bacterial Infections
08/2022 - 12/2019
4COVID-19
06/2022 - 09/2020
4Communicable Diseases (Infectious Diseases)
01/2022 - 02/2020
4Bacteremia
11/2020 - 07/2019
2Coinfection
06/2022 - 07/2021
2Sepsis (Septicemia)
06/2020 - 01/2020
2Clostridium Infections
12/2019 - 10/2019
1Soft Tissue Infections
12/2021
1Pseudomonas Infections
05/2021
1Nontuberculous Mycobacterium Infections
02/2021
1Pyelonephritis
12/2020
1Healthcare-Associated Pneumonia
12/2020
1Urinary Tract Infections (Urinary Tract Infection)
12/2020
1Peritonitis
02/2020
1Acute Kidney Injury (Acute Renal Failure)
12/2019
1Neutropenia
12/2019
1Exanthema (Rash)
12/2019
1Diarrhea
10/2019
1Hematologic Neoplasms (Hematological Malignancy)
10/2019
1Hepatitis C
07/2019
1Critical Illness (Critically Ill)
07/2019

Drug/Important Bio-Agent (IBA)

6Anti-Bacterial Agents (Antibiotics)IBA
06/2022 - 01/2019
5VancomycinFDA LinkGeneric
12/2021 - 10/2019
4Pharmaceutical PreparationsIBA
08/2022 - 07/2019
4DaptomycinFDA Link
11/2020 - 01/2020
3LipoglycopeptidesIBA
01/2020 - 01/2019
2Carbapenems (Carbapenem Antibiotics)IBA
08/2022 - 08/2021
2LactamsIBA
06/2020 - 01/2020
2ceftazidime drug combination avibactamIBA
06/2020 - 12/2019
1beta-LactamsIBA
01/2022
1Imipenem Drug Combination Cilastatin (Primaxin)FDA Link
12/2021
1relebactamIBA
12/2021
1meropenem and vaborbactamIBA
08/2021
1omadacyclineIBA
02/2021
1CefiderocolIBA
12/2020
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
11/2020
1CeftarolineFDA Link
11/2020
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
09/2020
1Dexamethasone (Maxidex)FDA LinkGeneric
09/2020
1remdesivirIBA
09/2020
1eravacyclineIBA
05/2020
1Blood Glucose (Blood Sugar)IBA
02/2020
1tazobactam drug combination ceftolozaneIBA
01/2020
1dalbavancinIBA
01/2019
1oritavancinIBA
01/2019

Therapy/Procedure

13Therapeutics
06/2022 - 01/2019
1Drug Therapy (Chemotherapy)
01/2022
1Transjugular Intrahepatic Portasystemic Shunt
01/2022
1Phage Therapy
05/2021
1Complementary Therapies (Alternative Medicine)
05/2021
1Length of Stay
02/2020
1Peritoneal Dialysis
02/2020
1Secondary Prevention
10/2019
1Hematopoietic Stem Cell Transplantation
10/2019